V

Velocity Clinical Research

Operates multi-site clinical trial network

Principal Investigator

Part-TimeDeadline 6/9/27
No salary listed
Expert
MD
East Greenwich, RI, USA
In PersonUp to 10% travel for project team meetings, client presentations, and other professional meetings or conferences.
Medical, Clinical & VeterinaryPhysicians & Surgeons

About the job

Requirements
  • Understanding of regulatory requirements, principles of Good Clinical Practice, and biomedical research ethics.
  • Ability to communicate effectively in a flexible and collaborative manner.
  • Critical thinking, dynamic problem-solving skills, and attention to detail.
  • Ability to travel for work-related purposes, up to 10% as needed for project team meetings, client presentations, and other professional meetings or conferences.
  • An M.D. or D.O. with an active medical license valid in the state where the research is conducted.
  • Training and certification in Good Clinical Practice.
  • Board certification or board eligibility in a specialty appropriate to the type of research conducted at the site.
  • Medical licensure valid in the state where the research is conducted.
  • Training and certification in Velocity-required trainings and standard operating procedures.
Responsibilities
  • Provide overall medical direction and medical review of protocols in conformance with the investigational plan and Good Clinical Practice.
  • Provide medical expertise and scientific feasibility assessments for new sponsor inquiries.
  • Ensure the safety and well-being of all study participants at the trial site.
  • Ensure data collected at the study site is credible and accurate.
  • Ensure the rights, integrity, and confidentiality of all trial participants at the site are protected.
  • Assist and provide guidance to clinical operations, research staff, and sponsor client managers as required.
  • Obtain and/or review participants’ medical histories.
  • Perform physical assessments, examinations, and study procedures required by study protocols.
  • Evaluate and interpret clinical data and diagnostic information, including X-rays, electrocardiograms, and laboratory work.
  • Immediately report serious adverse events or other abnormalities affecting participant safety to sponsors and the institutional review board as required by study-specific reporting guidelines.
  • Oversee the administration of investigational products.
  • Review and adhere to study protocols.
  • Maintain proper documentation.
  • Ensure the accuracy, completeness, legibility, and timeliness of reported data and consistency with source documents.
  • Ensure that the study, clinical trial protocol, informed consent form, recruitment materials, and other participant documents are approved by the institutional review board and comply with Good Clinical Practice and applicable regulatory requirements before and during the study.
  • Ensure that the institutional review board receives the investigator’s brochure, product monograph, or other product or intervention information needed to assess study risks.
  • Inform the institutional review board of protocol changes, changes to safety information, protocol deviations, and unanticipated problems during the study.
  • Remain familiar with the appropriate use of investigational products as described in the protocol, investigator’s brochure, product monograph, and other sponsor documents.
  • Comply with International Council for Harmonisation Good Clinical Practice and all applicable regulatory requirements.
  • Maintain trial documents according to applicable guidelines and regulatory requirements.
  • Ensure retention of essential documents for the required regulatory retention period.
  • Participate in monitoring visits and sponsor meetings and allow monitoring, auditing, and inspections by sponsors, institutional review board representatives, and regulatory agencies.
  • Provide research-related records to monitors, auditors, institutional review board representatives, and regulatory authorities.
  • Ensure participants are informed and receive appropriate therapy and follow-up if a trial is prematurely terminated or suspended.
  • Provide the institutional review board with a detailed written explanation of trial termination or suspension and provide it to the sponsor when required.

About the company

V

Velocity Clinical Research

View

Velocity Clinical Research operates the world’s largest network of fully integrated clinical research sites, with 70+ sites and 200+ investigators, collaborating with pharmaceutical and biotechnology companies to study new drugs, medical devices, diagnostics, and combination products. Its unified site solutions connect the right patients, investigators, and research staff across the U.S. and Europe, enabling efficient trial execution. A technology hub in India develops systems that leverage site, patient, and historical performance data to improve operations. The company’s approach centers on delivering high-quality data, excellent patient care, and greater efficiency for clinical trials at any scale. Its differentiators include a broad, integrated site network, global reach, and a focus on data-driven processes to speed research while maintaining quality.

Company Size

1,001-5,000

Company Stage

N/A

Total Funding

N/A

Headquarters

Cincinnati, Ohio

Founded

1999

Get referred to Velocity Clinical Research

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • On September 18, 2026, Velocity named Justin Starzyk CEO, signaling operator discipline.
  • Velocity's U.S. network enrolled 1,000 participants in 3.5 weeks for a vaccine trial.
  • Founder status in Advarra's AI governance council strengthens sponsor trust around trial automation.

What critics are saying

  • Justin Starzyk's arrival on September 18, 2026 confirms leadership churn at a scaled operator.
  • A centralized data model concentrates execution risk; one system failure hits all 70+ sites.
  • If big pharma shifts volume to hospital-owned networks, Velocity's standalone model loses its moat.

What makes Velocity Clinical Research unique

  • Velocity is the world's largest fully owned, integrated research-site network, spanning 70+ locations.
  • Its centralized EDC entered 97% of data within 24 hours on August 27, 2026.
  • Velocity's Stitch partnership lifted show-rates up to nine points across nearly 100,000 screenings.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • Paid Vacation
  • Paid Holidays
  • 401(k) Retirement Plan
  • 401(k) Company Match
  • Performance Bonus